Medtronic Scoops Up an Irish Endoscopy Diagnostics Player

Medtronic has added two endoscopic devices to its portfolio through an acquisition that could be worth up to $45 million, according to various media reports. The new acquisition, Galway, Ireland-based Crospon, provides Medtronic with a functional luminal imaging probe called the Endoflip. The device consists of a balloon catheter that is inserted into the area being measured and injected with a conductive solution to enable electrodes in the balloon to record voltage. The Endoflip builds up a picture of the geometry of the esophagus, pylorus, and anal sphincters using high-resolution impedance planimetry, according to Crospon. Crospon CEO John O’Dea broke the news last week through a LinkedIn post. Crospon is "delighted" to have Endoflip become part of Medtronic's gastrodiagnostic platform "sitting alongside category leaders such as Manoscan, Pillcam, SmartPill, Bravo, and Digitrapper," he said. At least four Medtronic executives also commented on O'Dea's post, offering congratulations and welcoming him to the company. In May Crospon received FDA clearance for the Endoflip system with Flip topography module, an imaging software that displays real-time esophageal contractility patterns on a touch-screen to help gastroenterologists investigate for conditions such as achalasia, GEJ outflow obstruction, and other disorders of peristalsis during endoscopy. The company also has a second device, the Esoflip, that is designed to work in conjunction with the Endoflip to enable...
Source: MDDI - Category: Medical Devices Authors: Tags: Medical Device Business Imaging Source Type: news